Christopher Hannum Ceriale, PA

Christopher Ceriale practices at UCSD Hillcrest Medical Center in San Diego, California.

Christopher Ceriale's NPI, 1255858221, was assigned on August 29, 2017. Christopher Ceriale holds California license 54651.

Christopher Ceriale's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Christopher Ceriale's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Christopher Ceriale is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Christopher Ceriale to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Christopher Ceriale practices. Vendor and product names are available with a free account.

Physician assistant is Christopher Ceriale's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Christopher Ceriale is licensed in California.

Dmand AI lists bladder disease, enlarged prostate and UTI among the conditions Christopher Ceriale treats.

CMS data shows 309 Medicare services from Christopher Ceriale across 5 procedure codes in 2024, for 211 Medicare patients. Medicare paid $15,952 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 211 Medicare patients who saw Christopher Ceriale in 2024. The largest group is 65 to 74, with 104 patients. 69% of them have high blood pressure, and 68% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Christopher Ceriale's median patient age at 58, with 34% women.

In 2024, Christopher Ceriale wrote 2,071 Medicare Part D claims for 475 patients. 77% of them were for generic drugs. CMS names the drug for 1,863 of them, across 34 drugs with 11 or more claims each, at $771,614 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Christopher Ceriale for performance year 2024, reported as part of a group. Christopher Ceriale accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Christopher Ceriale as offering telehealth.

CMS Open Payments shows 34 general payments to Christopher Ceriale from 16 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Endo USA, Inc. paid the most, $136.